The COVID-19 pandemic has brought unprecedented disruption and complexity to the world we live in today. Various social needs have been brought to the forefront, demanding innovation in the form of new ideas and solutions. We now have to consider if our existing models of financing and supporting these innovations are sufficient to create scalable and sustainable impact and financial returns.
The importance of innovative technologies and concepts in building a robust healthcare system has never been more clear. As demand has risen sharply, various healthcare and MedTech startups have come forward with interventions that could revolutionize the world of health and wellbeing. This is a timely opportunity to explore how we might best leverage financial capital to amplify innovative activity, scale social impact, and achieve sustainable financial returns.
In partnership with EY, Menzies Foundation, MedTech Actuator, and Brightlight, AVPN is pleased to present an in-person event in Singapore showcasing emerging opportunities in the healthcare and MedTech sector in Asia-Pacific. The event will host a series of interesting key speakers and an exciting diverse panel of innovative healthcare entrepreneurs.
- Learn about the impact demonstrated by investments in the healthcare and MedTech sector
- Understand progressive venture capital and its potential as a scalable investment vehicle
- Hear more about emerging opportunities in the MedTech sector for outstanding impact and financial returns
- Understand how MedTech can be leveraged to address the SDGs and key issues facing our world today
If you are keen to participate in the event or have any questions, please reach out to [email protected]. This invite-only in-person event is open to 25 participants, and registrations will be accepted on a first-come-first-served basis.
To learn more about progressive venture capital & impact, please read this blogpost by Dr Buzz Palmer.
CEO, Menzies Foundation
Liz brings over 20 years’ experience in social impact, philanthropy and leadership development, to the role of Chief Executive Officer at the Menzies Foundation. She has worked across the not-for-profit, university, government and private sectors, including setting up her own businesses.
Liz was instrumental in establishing and managing both the Centre for Ethical Leadership and the Asia Pacific Centre for Social Impact with the Business School at the University of Melbourne.
Liz was awarded a research fellowship to investigate best practice in philanthropy, working alongside The Trust Company philanthropy team to develop the Engaged Philanthropy model. This work culminated in the national launch of the Best Practice in Philanthropy Report in 2018 and Philanthropy – The Continued Journey to Real Impact and Better Practice in 2021.
Chief Investment Officer, Brightlight
Tim Macready is the Chief Investment Officer of Brightlight. He partners with clients to help them align all aspects of their portfolio with their values while also leading Brightlights research capability across impact and value-driven investment opportunities.
Vastly experienced in impact, faith, and values-driven investment, before joining Brightlight, Tim spent 15 years as the Chief Investment Officer of Christian Super, an Australian superannuation fund with 30,000 members. At Christian Super, he was responsible for all aspects of investment portfolios strategy, design, and construction to deliver a $1.5bn portfolio that was values aligned and consistently achieved investment objectives. Tim’s qualifications and experience in values and faith-driven investment are first-class.
His formal education includes a Bachelor of Commerce (Actuarial Studies) from Macquarie University, a Master of Divinity from the Australian College of Theology, and Certified Investment Management Analyst accreditation. Insightful and transformative, Tim believes every client has different needs and objectives, requiring a different approach to values alignment that goes beyond applying a single framework to a client’s portfolio. He is passionate about ensuring Brightlight’s clients are equipped and served to align their portfolios with their values.
Dr Vishaal Kishore
Managing Partner, Synthesis Capital
Co-founder, MedTech Actuator
Dr Vishaal Kishore is a leading expert in system innovation and transformation, with a focus on health and inclusive economic development.
Political economist, lawyer and commentator. Co-founder of the MedTech Actuator. Professor of Innovation & Public Policy at RMIT University, where he leads the Cisco Health Transformation Lab. Vishaal is heavily involved in early-stage venture capital and investment initiatives, and regularly advises governments, NGOs and corporates in respect of strategy, public policy and innovation.
Holding a doctorate from Harvard University. Served as Deputy Secretary at the Department of Health & Human Services; Director for government strategy within EY’s management consulting practice; and a Mergers & Acquisitions lawyer at Mallesons Stephen Jaques and Freehills.
Lincoln is the co-founder at XCLR8 Technologies, a Singapore-based innovative HealthTech company that develops wearable sensors and applications to enable remote physiotherapy. XCLR8 leverages the latest IoT technologies to increase convenience for patients, increase recovery speed and reduce costs for physical therapy. Similarly they provide a solution to practitioners to reach more patients and reduce operating cost.
Amy is a co-founder and CTO at Ventora Medical, a Melbourne-based medical device start-up with a mission to help premature babies breathe. Ventora Medical is developing a device that will provide minimally invasive real-time monitoring of the airway pressure for preterm infants on non-invasive respiratory support. The device will provide accurate clinical information to enable clinicians to be proactive in their treatment and provide evidence-based care.
JianMing is the co-founder at Moon Technologies, a Singapore-based medical device startup using Augmented Reality Smartglasses to deliver real-time actionable insights to paramedics. Using a combination of an eye-tracking user interface system and integrated virtual search systems, Moon Technologies allows paramedics to search and retrieve patient data with their eyes while assessing vital signs.
Dr Buzz Palmer
One of Australia’s most prominent voices in health entrepreneurship. He co-founded the MedTech Actuator –in 2018 and is strongly involved in a number of venture capital and technology/ product development initiatives. A regular advisor to governments at all levels and a Professor of Entrepreneurship at Monash University Business School, passionate about catalyzing innovation and supporting the founders who drive it.
Dr. Num Tanthuwanit
EY-Parthenon Partner, Health, Ernst & Young LLP
Dr. Num has extensive experience in clinical, operational, executive and strategic board roles in the health sector. He assists tertiary hospitals in improving the patient experience and service standards; procurement operations; cost management; business strategy and innovation; physician recruitment as well as quality assurance, improvement and accreditation. He also helps them to develop new clinical programs and services as well as assess and implement new technologies.
Previously Group CEO of a leading hospital in Indonesia and the CEO of a major private health care facility in Thailand, Dr. Num also practiced as a specialist rehabilitation physician in Australia’s and Thailand’s public and private sectors. A Fellow of the Australasian Faculty of Rehabilitation Medicine, Royal Australasian College of Physicians, he holds an MBBS from the University of Melbourne, Australia, and an MSc in Management from Stanford University, US.